Results 41 to 50 of about 275,119 (174)

Evolution of Endoscopic and Histologic Assessment of Eosinophilic Esophagitis in Europe and Evolution of the Diagnostic Delay: Data From the EUREOS EoE CONNECT Registry

United European Gastroenterology Journal, Volume 14, Issue 7, September 2026.
ABSTRACT Background Endoscopy with histopathological assessment of esophageal biopsies is the cornerstone for the diagnosis and phenotypic characterization of eosinophilic esophagitis (EoE). Objective To evaluate temporal trends in endoscopic assessment and biopsy sampling practices for EoE in a large European cohort and their association with temporal
E. Grueso‐Navarro, E. Dilaghi, J. Fernández‐Pacheco, E. Amorena, E. V. Savarino, L. Blas‐Jhon, I. Pérez‐Martínez, A. Granja‐Navacerrada, D. Guagnozzi, L. Martín‐Asenjo, G. Pellegatta, M. Coletta, C. García‐Suárez, S. de la Riva, L. de la Peña‐Negro, E. Betoré, A. L. Krarup, J. Barrio, M. Votto, L. Bujanda, S. Fernández‐Fernández, J. E. Naves, A. González‐Almeida, R. Honrubia‐López, S. Carrión, S. Oliva, C. Caño‐Cerdán, M. L. Masiques‐Mas, S. Espina‐Cadena, J. González‐Cervera, S. Casabona‐Francés, J. Nicolay‐Maneru, V. Úbeda‐Vargas, M. Ghisa, P. Romo‐de Arriba, C. Donado, A. Benagues, V. Martín‐Domínguez, O. Nantes‐Castillejo, L. Arias‐González, D. Maniero, H. Moreira‐González, I. Maray, J. Barrio‐Torres, M. T. Pérez‐Fernández, M. Ostiz‐Llanos, L. Rodríguez‐Alcolado, A. M. Cabrera‐Martínez, E. J. Laserna‐Mendieta, C. Santander, A. J. Lucendo   +50 more
wiley   +1 more source

Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study. [PDF]

, 2021
To assess cancer incidence in the UK cystic fibrosis (CF) population and determine the associated risk factors, we undertook a nested case-control study of patients with CF, registered with the UK CF Registry.
Mentzakis, Emmanouil, Peckham, Daniel, Cullinan, P., Mentzakis, E., Carr, S.B., Bilton, D., Simmonds, Nicholas J, Archangelidi, Olga, Archangelidi, O., Simmonds, N.J., Bilton, Diana, Simmonds, N. J., Peckham, D., Carr, S. B., Cullinan, Paul, Carr, Siobhán B   +15 more
core   +1 more source

GATA4 como biomarcador y diana terapéutica de la fibrosis hepática [PDF]

, 2015
Motivación: La fibrosis hepática, y en último término la cirrosis, es una enfermedad con una elevada incidencia y es responsable del 1,8 % de la mortalidad mundial (1).
Villamayor Coronado, Laura, Rojas, Anabel   +1 more
core   +1 more source

Production of septal fibrosis of the liver by means of foreign protein injections into rats

Revista da Sociedade Brasileira de Medicina Tropical, 2003
Similarities and differences in antigenic humoral responses and electrophoretic patterns between Capillaria hepatica and pig-serum were investigated as a contribution to the understanding of hepatic fibrosis induced by the parenteral administration of ...
Bruna Magalhães Gotardo, Rodrigo Guimarães Andrade, Ludmila Fernandes Oliveira, Zilton A. Andrade   +3 more
doaj  

Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers [PDF]

, 2012
Background: Liver fibrosis in human immunodeficiency virus (HIV)-infected individuals is mostly attributable to co-infection with hepatitis B or C. The impact of other risk factors, including prolonged exposure to combined antiretroviral therapy (cART ...
Annika Vermehren, Stefan Zeuzem, Gute, Peter, Poynard, Thierry, Friedrich-Rust, Mireen, Vermehren, Johannes, Peter Gute, Sarrazin, Christoph, Christoph Sarrazin, Amina Carlebach, Johannes Vermehren, Carlebach, Amina, Axel Mueller, Vermehren, Annika, Lutz, Thomas, Forestier, Nicole, Herrmann, Eva, Thomas Lutz, Thierry Poynard, Mireen Friedrich-Rust, Knecht, Gaby, Wolf Peter Hofmann, Hofmann, Wolf-Peter, Eva Herrmann, Nicole Forestier, Gaby Knecht, Mueller, Axel, Zeuzem, Stefan   +27 more
core   +2 more sources

Predictores de fibrosis hepática en pacientes con esteatohepatitis no alcohólica

Correo Científico Médico, 2014
Introducción: la enfermedad hepática por depósito de grasa no alcohólica se considera la causa más frecuente de hepatopatía crónica; hasta la mitad de los  pacientes pueden desarrollar fibrosis avanzada.
Jorge Omar Cabrera Lavernia, Yoel Mario Ricardo Serrano, Cristina Beatriz Noguera Berchí   +2 more
doaj  

Correlación de la cuantificación de fibrosis hepática por morfometría mediante HepaScan con el análisis de las biopsias hepáticas. Estudio piloto

Gaceta Médica de México, 2023
Antecedentes: El estándar de oro para determinar el grado de fibrosis hepática (FH) continúa siendo la evaluación de la biopsia. Existen técnicas de morfometría que permiten cuantificar la FH en estudios histopatológicos.
Nathalie Alemán-García, José A. García-García, Marco A. Durán-Padilla, María E. Gutiérrez-Díaz-de Ceballos, Thelma Rizo-Pica, Ana del C. Susunaga-Notario, Celia Sánchez-Pérez   +6 more
doaj   +1 more source

Resmetirom Ameliorates Fibrogenesis in Hepatic Stellate Cells via Thyroid Hormone Receptor Alpha‐Fatty‐Acid Amide Hydrolase 1 Signaling Pathway

MedComm, Volume 7, Issue 8, August 2026.
1. Resmetirom attenuates the activation of HSCs induced in in vitro and in vivo models. 2. Resmetirom attenuates the activation of HSCs through its specific action on the thyroid hormone receptor alpha. 3. Resmetirom requires fatty‐acid amide hydrolase 1 to reduce HSC activation. ABSTRACT Resmetirom is a liver‐directed, thyroid hormone receptor β (THRβ)
Eva Novoa, Alba Cabaleiro, Borja López‐Picallo, Natalia da Silva Lima, Cristina Riobello, Carmen Pena, Jose Iglesias‐Moure, Ana Senra, Maria Luz Martínez‐Chantar, Anabel Fernandez‐Iglesias, Jordi Gracia‐Sancho, Susana Bravo, Carlos Dieguez, Marta Varela‐Rey, Vincent Prevot, Markus Schwaninger, Miguel López, Rubén Nogueiras   +17 more
wiley   +1 more source

Role of partial hepatectomy on Capillaria hepatica-induced hepatic fibrosis in rats Papel da hepatectomia parcial sobre a fibrose septal do fígado induzida pela Capillaria hepatica em ratos

Revista da Sociedade Brasileira de Medicina Tropical, 2007
It is known that hepatic fibrosis may regress following partial hepatectomy, since the hepatic parenchyma regenerates very rapidly, but not the excess of fibrous tissue.
Carolina Cincurá Silva Santos, Záira Onofre-Nunes, Zilton Araujo Andrade   +2 more
doaj   +1 more source

A compendium of extracellular vesicle biogenesis inhibitors: From bench to bedside

Interdisciplinary Medicine, Volume 4, Issue 4, July 2026.
This review explores a decade of research on extracellular vesicles (EVs), detailing their biogenesis and roles in health and disease. It emphasizes EVs' relevance for potential medical applications covering various conditions such as cancer, neurodegeneration, inflammation, and infectious diseases, bridging experimental findings with clinical ...
Stefano Vecchione, Ana Talamillo, Juan M. Falcón‐Pérez   +2 more
wiley   +1 more source